Predictors of long-term compliance with continuous positive airway pressure

Thorax

Volumn 65, Issue 9, 2010, Pages 829-832

  Kohler, Malcolm ^a,b   Smith, Debbie ^b   Tippett, Victoria ^b   Stradling, John R ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MOVEMENT; BREATHING PATTERN; DAYTIME SOMNOLENCE; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; GENDER; GROUPS BY AGE; HEART RATE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NECK; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULSE OXIMETRY; SLEEP DISORDERED BREATHING; SNORING; TREATMENT DURATION; ANTHROPOMETRY; EPIDEMIOLOGY; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; SLEEP APNEA, OBSTRUCTIVE;

ADULT; ANTHROPOMETRY; CONTINUOUS POSITIVE AIRWAY PRESSURE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SLEEP APNEA, OBSTRUCTIVE;

EID: 77956803739     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.135848     Document Type: Article

References (16)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
2. Siccoli MM, Pepperell JC, Kohler M, et al. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008;31:1551-8.
3. George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001;56:508-12.
4. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159-65.
5. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
6. Krieger J, Kurtz D, Petiau C, et al. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep 1996;19:S136-43.
7. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:1108-14.
8. Guest JF, Helter MT, Morga A, et al. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK. Thorax 2008;63:860-5.
9. Pitson DJ, Stradling JR. Autonomic markers of arousal during sleep in patients undergoing investigation for obstructive sleep apnoea, their relationship to EEG arousals, respiratory events and subjective sleepiness. J Sleep Res 1998;7:53-60.
10. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10.
11. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
12. Meurice J, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994;105:429-33.
13. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.
14. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008;117:2270-8.
15. Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res 1997;6:142-5.
16. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy. Proc Am Thorac Soc 2008;5:173-8.